Hosted by HealthpointCapital
Hosted by HealthpointCapital
TendoNova is an early commercial stage medtech company closing the treatment gap in musculoskeletal care between conservative treatment and surgery. Conditions like tennis elbow, plantar fasciitis, Achilles tendinopathy, and rotator cuff tendinopathy can progress to tendinosis, a form of tendon damage affecting patients who’ve exhausted physical therapy, rest, and cortisone injections, representing a $1B annual US market with few options short of invasive surgery. TendoNova’s Ocelot System, FDA 510(k) cleared and reimbursed under existing CPT codes, is a wireless, handheld, micro-invasive platform performed directly in the physician’s office, with more than 80% of patients reporting meaningful, sustained improvement across early clinical studies. TendoNova now serves customer accounts nationwide, with revenue accelerating as it scales toward broader adoption.
